Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Heres the thing though: we dont know if that necessarily equates to better results compared to traditional yerba mate options
Emerging multi-agonists such as retatrutide (GLP-1/GIP/glucagon triple agonist) and PTT-A (novel unimolecular peptide tetra-agonist targeting GLP-1, GIP, glucagon and amylin receptors) further expand this concept
Compared to traditional addiction treatments, GLP-1RAs offer a novel mechanism by targeting metabolic and neuroendocrine pathways rather than direct neurotransmitter modulation
By taking this step, youre not just considering a treatment option but taking a leap towards a healthier, more vibrant life
Grotto D, Bueno DCR, Ramos GKDA, da Costa SR, Spim SRV, Gerenutti M
